Abstract:Purpose: Mutations in signal transducer and activator of transcription 1 (STAT1) cause a broad spectrum of disease phenotypes. Heterozygous STAT1 loss-of-function (LOF) mutations cause Mendelian susceptibility to mycobacterial diseases (MSMD) infection, which is attributable to impaired IFN-γ signaling. The identification of novel mutations may extend the phenotypes associated with autosomal dominant (AD) STAT1 deficiency. Methods: Five patients with heterozygous STAT1 variations were recruited and their clinical and immunologic phenotypes were analyzed, with particular reference to JAK-STAT1 signaling pathways. Results: Four, heterozygous STAT1 deficiency mutations were identified, three of which were novel mutations. Two of the mutations were previously unreported mRNA splicing mutations in AD STAT1-deficient patients. Patients with heterozygous STAT1 deficiency suffered not only mycobacterial infection, but also intracellular non-mycobacterial bacterial infection and congenital multiple malformations. AD-LOF mutation impaired IFN-γ-mediated STAT1 phosphorylation, gamma-activated sequence (GAS), and IFN-stimulated response element (ISRE) transcription activity and IFN-induced gene expression to different extents, which might account for the diverse clinical manifestations observed in these patients. Conclusion: The infectious disease susceptibility and phenotypic spectrum of patients with AD STAT1-LOF are broader than simply MSMD. The susceptibility to infections and immunological deficiency phenotypes, observed in AD-LOF patients, confirms the importance of STAT1 in host-pathogen interaction and immunity. However, variability in the nature and extent of these phenotypes suggests that functional analysis is required to identify accurately novel, heterozygous STAT1 mutations, associated with pathogenicity. Aberrant splice of STAT1 RNA could result in AD-LOF for STAT1 signaling which need more cases for confirmation.

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

ATAD3B is a Mitophagy Receptor Mediating Clearance of Oxidative Stress‐induced Damaged Mitochondrial DNA

Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT

A Deafness-Associated Mitochondrial DNA Mutation Altered the Trnaser(ucn) Metabolism and Mitochondrial Function.

Antigen Receptor Stimulation Induces Purifying Selection Against Pathogenic Mitochondrial Trna Mutations.

cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing

Antigen receptor stimulation drives selection against pathogenic mtDNA variants that dysregulate lymphocyte responses

deficiency triggers autoinflammation via cGAS-STING activation

Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes

Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner

Mutations in mitochondrial ATAD3 gene and disease, lessons from in vivo models

Fumarate induces vesicular release of mtDNA to drive innate immunity

Expanding the phenotype of de novo SLC25A4-linked mitochondrial disease to include mild myopathy

Ancestral allele of DNA polymerase gamma modifies antiviral tolerance

Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity

ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling

Circulating Cell-Free Mtdna Release is Associated with the Activation of Cgas-Sting Pathway and Inflammation in Mitochondrial Diseases

IRGM1 links mitochondrial quality control to autoimmunity

Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy

Molecular Basis of the Pathogenic Mechanism Induced by the m.9191T>C Mutation in Mitochondrial ATP6 Gene

Molecular basis of diseases caused by the mtDNA mutation m.8969G>A in the subunit a of ATP synthase.